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(3S,8aS)-3-isobutylhexahy
dropyrrolo[1,2-a]pyrazine-1,
4-dione;
(3R,8aS)-3-isobutylhexahy
dropyrrolo[1,2-a]pyrazine-1,
4-dioneAbstract Sediment samples from the mangrove ecosystem of Nizampatnam have been analyzed
for actinomycetes as an elite source to screen for the formulation and production of antimicrobial
and cytotoxic compounds. The actinomycetes strain VUK-10 has an interesting bioactivity profile
and was isolated during our systematic study of mangrove actinomycetes. It was identified as
Pseudonocardia endophytica with the aid of polyphasic taxonomy. The ethyl acetate extract of
the actinobacterial culture filtrate has been purified by gel-filtration and silica gel column chromato-
graphic purifications led to the isolation of two diketopiperazine compounds, (3S,8aS)-3-isobutyl
hexahydropyrrolo[1,2-a]pyrazine-1,4-dione (1) and (3R,8aS)-3-isobutylhexahydropyrrolo[1,2-a]pyr
azine-1,4-dione (2). The compounds listed, alluring cytotoxic activity against MDA-MB-231, HeLa,
MCF-7 and OAW-42 cancer cell lines and also exhibited antimicrobial activities against gram-
positive, gram-negative bacteria and fungi. Compound 1 recorded significant antibacterial activity
against Xanthomonas campestris and Escherichia coli (8 lg/ml) and compound 2 presented highest
activity against Bacillus subtilis (4 lg/ml). Compounds 1 and 2 were active against pathogenic fungi
to plants and human beings. The activity was compared with griseofulvin and amphotericin-B,
which are standard fungicides. The activity of 16 lg/ml by compound 1 was recorded against
Epidermophyton floccosum; an anthropophilic dermatophyte responsible for tinea pedis, tinea cruris
and tinea corporis. To the best of our knowledge this is the first narration on the isolation of supra
said compounds from the genus Pseudonocardia.
 2016 National Institute of Oceanography and Fisheries. Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).522510,
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The microbial secondary metabolites represent a boundless
source of compoundswith contemporary structures and impres-
sive biological activities (Alan et al., 2015). Multiple products
originating from microbial fermentation or from chemically
altered products have been extensively availed, in agriculture,
veterinary andpharmaceutical industries. The prospect of devel-
oping non-conventional bioactive compounds, depends on the
number of strains scrutinized, their heterogeneity, distinctive-
ness and enabling to produce bioactive secondary metabolites
(Donadio et al., 2002). The mangrove ecosystem is absolutely
realistic, which is a dependable neighborhood in tropical and
subtropical regions of the world for structurally complex and
biologically active natural products. The saline mangrove
ecosystem is fortified with organic matter and is sandwiched
between terrestrial and marine environment (Kizhekkedathu
and Parukuttyyamma, 2005). It is a classical habitat, studded
with a divergent group of microorganisms (Arifuzzaman
et al., 2010) and a hub of contemporary group of actinomycetes
to experiment for new bioactive secondary metabolites.
Actinomycetes are being selected as a gifted, natural source
for clinically active antibiotics. Most of them are too compli-
cated to be blended by combinatorial chemistry. The therapeutic
benefit of actinomycetes that is not only useful in the develop-
ment of life saving drugs chiefly antimicrobial and cytotoxic
agents, but also a profit generating podium to the pharmaceuti-
cal industry, is irrefutable (Baltz, 2007). As per the available lit-
erature about 4607 patents have been accorded on actinomycete
associated products and processes. Out of 22,500 analyzed
bioactive secondary metabolites, 10,100 (45%) are from actino-
mycetes; of which 7630 from Streptomycetes while 2470 from
rare actinomycetes (Berdy, 2005). Based on the accredited infor-
mation the Pseudonocardia, a rare actinomycetes genus is less
scrutinized for bioactive metabolites than the other strains of
the order Actinomycetales (Gavin et al., 2012). The genus
Pseudonocardia, a new exclusive strain of the group actino-
mycetes was originally proposed by Henssen (1957), for myco-
lateless, nocardioform actinomycetes with a type IV cell wall.
The bioactive compounds discovered from Pseudonocardia
include azureomycins A and B (Omura et al., 1979); new quino-
lone compounds (Dekker et al., 1998); Pseudonocardones A, B
and C, 6-deoxy-8-O-methylrabilomycin (Gavin et al., 2012);
dentigerumycin (Oh et al., 2009); phenazostatin D (Maskey
et al., 2003) and NPP (Lee et al., 2012) that showed potential
antimicrobial and cytotoxic properties.
In thepursuit of clinically beneficial bioactivemetabolites,we
identified and isolated actinobacterium strain VUK-10 from
unexplored mangrove sediment samples of Nizampatnam,
which endorsedabroad spectrumantimicrobial activity andalso
probed for the active constituents of actinobacterium.Our paper
vividly illustrates the process of fermentation, isolation, struc-
tural elucidation and biological assessment of purified com-
pounds from the strain Pseudonocardia endophytica VUK-10.
Materials and methods
Sampling
Sediment samples from Nizampatnam mangrove ecosystem
(Lat. 155400N; Long. 804000E) stationed along the south eastcoast of Andhra Pradesh were collected at bimonthly intervals
from April 2010 to February 2011. Samples were collected
from 6 to 10 cm depth and transported to laboratory in sterile
bags and air dried at room temperature.
Isolation
The air dried sediment sample was subjected to dry heat pre-
treatment at 55 C for 15 min to increase the actinobacterial
population in the sample and to restrain the unwanted con-
taminants like fungi and bacteria. The pre-treated sample
(1 g) was suspended in 100 ml of quarter strength ringer’s solu-
tion, homogenized by vortexing. 100 ll of 104 dilution was
spread across on asparagine glucose agar medium supple-
mented with nalidixic acid (25 lg/ml) and secnidazole
(25 lg/ml) followed by incubation at 30 C for one week.
Morphologically distinct strains were selectively segregated
and maintained by sub culturing on yeast extract–malt extract
dextrose (YMD) agar medium at 4 C for further study.
Identification
All the 55 strains isolated in this study were screened for the
production of bioactive metabolites and 28 strains out of
which are known for their antimicrobial activity. Of the 28
strains, 19 strains have been active against all the test microor-
ganisms. Metabolites of the strain VUK-10 showed significant
antimicrobial activity when compared to other tested ones.
The strain was identified as P. endophytica by polyphasic tax-
onomy. JN087501 is the accession number of the NCBI Gen-
Bank for the 16S rRNA gene sequence of P. endophytica. Pure
culture of actinobacteria was maintained on YMD agar slants
at 4 C for further study (Ushakiranmayi et al., 2012).
Extraction and metabolite profiling
A loopful culture of P. endophytica VUK-10 was cultivated in
YMD broth (seed broth) and incubated on a rotary shaker
(250 rpm) at 35 C. After 48 h of incubation, the seed culture
at the rate of 10% was transferred to the optimized production
medium. The production medium consisted of glucose (8%),
soy-peptone (1%), yeast extract (0.2%), meat extract (0.1%),
CaCO3 (0.3%), K2HPO4 (0.03%), MgSO4 (0.1%), FeSO4
(0.005%) and NaCl (3%) with pH adjusted to 7.0. After
48 h incubation, the seed culture at the rate of 10% was trans-
ferred to the optimized production medium.
Purification and structural elucidation of bioactive metabolites
The ethyl acetate crude extract was subjected to Sephadex
LH-20 gel filtration chromatography (36  2.5 cm, Sephadex
G-15) by using dichloromethane/methanol (1:1) as the eluent,
resulting in seven fractions. Based on the 1H NMR spectral
data and bio-active screening, the fraction III (1.95 g) was
selected for further studies and subjected to silica gel column
chromatography (100–200 mesh), which afforded fractions
1–7. Based on TLC monitoring and NMR spectral data, frac-
tion 7 was selected for further purification. Fraction 7 (360 mg)
was subjected to further purification by silica gel column chro-
matography using dichloromethane/acetone (75:25) that
afforded sub fractions A and B. The sub-fractions A and B
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using dichloromethane/acetonitrile (85:15) and dichloro-
methane/isopropanol (95:5) and yielded compound 1 (18 mg)
and compound 2 (51 mg), respectively. The structural elucida-
tion of compounds 1 and 2 was carried out by detailed inter-
pretation of NMR, mass, FTIR spectroscopic data.
Test microorganisms
Gram positive bacteria: Bacillus cereus (MTCC 430), Strepto-
coccus mutans (MTCC 497), Staphylococcus aureus (MTCC
3160), Staphylococcus epidermis (MTCC 120), Bacillus subtilis
(ATCC 6633), Bacillus megaterium (NCIM 2187); gram nega-
tive bacteria: Escherichia coli (ATCC 35218), Pseudomonas
aeruginosa (ATCC 9027), Proteus vulgaris (MTCC 7299),
Serratia marcescens (MTCC 118) Xanthomonas campestris
(MTCC 2286), Xanthomonas malvacearum (NCIM 2954) and
Salmonella typhi (ATCC 14028); medically important der-
matophytes: Candida albicans (ATCC 10231) and Epidermo-
phyton floccosum (MTCC 145); medically and agriculturally
important filamentous fungi: Aspergillus niger (ATCC 1015),
Aspergillus flavus (ATCC 9643), Fusarium oxysporum (MTCC
3075), Fusarium solani (MTCC 4634), Penicillium citrinum
(MTCC 6489), Verticillium alboatrum and Alternaria alternata
(MTCC 6572). The test microorganisms used in the present
study were procured from ATCC, University Boulevard,
Manassas, USA and MTCC, Chandigarh, NCIM, Pune, India
and preserved at 4 C.
Minimum inhibitory concentration (MIC) assay
The antimicrobial spectra of the bioactive compounds of the
strain were determined in terms of minimum inhibitory con-
centration (MIC) against a wide variety of gram-positive and
gram negative bacteria and fungi using the agar plate diffusion
assay (Cappuccino and Sherman, 2004). Triplicate sets of the
plates were maintained for each concentration of the test sam-
ple. Mueller–Hinton agar and Czapek–Dox agar media were
prepared to grow the bacteria and fungi, respectively. The
purified compounds were dissolved in dimethyl sulfoxide at
concentrations ranging from 0 to 1000 lg/ml and used to assay
against the supra mentioned test bacteria and fungi. The inoc-
ulated plates were examined after 24–48 h of incubation at
37 C for bacteria and 48–72 h at 28 C for fungi. The lowest
concentration of the bioactive metabolites exhibiting signifi-
cant antimicrobial activity against the test microorganisms
was taken as the MIC of the compound.
Cell lines and culture conditions
Cell lines for testing in vitro cytotoxicity: human breast adeno
carcinoma cell line (MDA-MB-231), human cervical cancer
cell line (HeLa), human ovarian cyst adenocarcinoma cell line
(OAW-42) and human breast adenocarcinoma cell lines
(MCF-7) (cell lines reported to be resistant to cancer drugs).
The cell lines used in the present study were obtained from
National Centre for Cell Science, Pune, India. Cell lines
MDA-MB-231, HeLa and OAW-42 were cultured on Dul-
becco’s modified Eagle’s medium supplemented with fetal
bovine serum (10%; (v/v)), L-glutamine (2 mM), penicillin
(10 units/ml) and streptomycin (10 lg/ml), while breast cancercell line MCF-7 was cultured on Roswell Park Memorial Insti-
tute medium 1640 supplemented with fetal bovine serum (10%;
(v/v)), L-glutamine (2 mM), penicillin (10 units/ml) and strep-
tomycin (10 lg/ml), all in a humidified atmosphere (95%) with
5% of CO2 at 37 C.
Cell proliferation (MTT) assay
The cytotoxicity of the compounds was assessed on the basis of
the measurement of the in vitro growth in 96-well plates by cell
mediated reduction of tetrazolium salt to water insoluble for-
mazan crystals, as per the micro culture MTT assay
(Mosmann, 1983). Cells were seeded in 96-well microtiter
plates at a density of 5  103 per well (100 ll) containing
0.1 ml of medium. After overnight incubation, the cells were
treated with different test concentrations of bioactive com-
pounds (10, 100, 1000 and 5000 nM) at identical conditions
with three replicates of each concentration. After 24 h of incu-
bation, the cell viability was assessed by adding 20 ll of MTT
(5 mg/ml in PBS) per well and the plates were incubated at
37 C for 4 h. The formazan crystals formed in the cells were
dissolved with 100 ll of 0.1% acidified isopropanol, and the
rate of color development was measured at 570 nm using a
microplate reader. The IC50 values (50% inhibitory concentra-
tion) of the compounds were calculated using Sigma Plot soft-
ware with reference to that of Taxol as standard. All the
experiments were carried out in triplicates.Results
Purification and structural elucidation of bioactive metabolites
Compound 1 was obtained as a colorless amorphous solid,
wholly soluble in dimethylsulfoxide, methanol, ethanol and
chloroform, ½a25D -78.68 (c 0.11, CHCl3). The 1H NMR spec-
trum of compound 1 showed signals at d 6.98 (s, 1H); 4.06
(t, 1H, J= 6.98 Hz); 3.91 (m, 1H); 3.67–3.46 (dm, 2H); 3.28
(m, 1H); 2.08–1.67 (m, 4H); 1.62 (m, 2H); 0.98 (d, 3H,
J= 6.42 Hz); and 0.92 (d, 3H, J= 6.42 Hz) (Supplementary
Fig. A); while 13C exhibited 10 signals at d 169.56; 166.36;
58.00; 56.25; 45.56; 42.57; 30.86; 24.43; 22.98 and 21.36 (Sup-
plementary Fig. B). EIMS analysis of the compound gave a
molecular ion m/z at 211 (M+H); 233 (M+ Na) (Supple-
mentary Fig. C). The IR spectrum exhibited absorption bands
at Vmax 3242, 2958, 1741, 1665, 1447 and 758 cm
1
(Supplementary Fig. D). Based on the above spectral data,
bioactive compound 1 was identified as (3S,8aS)-3-isobutylhex
ahydropyrrolo[1,2-a]pyrazine-1,4-dione (Cyclo (D-Pro-D-Leu)
with the molecular formula of C11H18N2O2 (Fig. 1).
Compound 2 was obtained as a colorless amorphous solid,
freely soluble in methanol, ethanol and ethyl acetate,
½a25D þ 33:57 (c 1.9, CHCl3). The 1H NMR spectrum of the
compound showed signals at d 6.37 (bs, 1H); 4.09 (t, 1H,
J= 7.55 Hz); 3.98 (dd, 1H, J= 3.02, 9.06 Hz); 3.62–3.45
(m, 2H); 2.37–2.27 (m, 1H); 2.16–1.94 (m, 3H); 1.93–1.67 (m,
2H); 1.50 (m, 1H); 0.96 (d, 3H, J= 6.79 Hz); and 0.91 (d,
3H, J= 6.79 Hz) (Supplementary Fig. E), while 13C exhibited
10 signals at d 171.4; 167.1; 59.1; 53.4; 45.6; 36.7; 28.2; 24.8;
22.8 and 21.2 (Supplementary Fig. F). EIMS analysis of the
compound gave a molecular ion m/z at 211 (M+H); 233 (M
Table 1 Minimum inhibitory concentration (MIC) of bioac-
tive compounds isolated from Pseudonocardia endophytica
VUK-10 (MIC-(lg/ml)) against test bacteria.
Test microorganisms Compound-1 Compound-2 Tetracycline
Staphylococcus aureus 64 128 32
Streptococcus mutans 128 256 32
S. epidermis 64 64 16
Xanthomonas campestris 8 16 16
X. malvacearum 32 64 8
Bacillus subtilis 32 4 32
B. megaterium 128 64 16
B. cereus 64 64 8
Escherichia coli 8 16 8
Pseudomonas aeruginosa 32 64 8
Serratia marcescens 64 64 32
Proteus vulgaris 128 256 16
Salmonella typhi 128 128 8
Compound-1: (3S,8aS)-3-isobutylhexahydropyrrolo[1,2-a]pyr-
azine-1,4-dione.
Compound-2: (3R, 8aS)-3-isobutylhexahydropyrrolo[1,2-a]pyr-
azine-1,4-dione.
Data were statistically analyzed by a one way ANOVA variance
and found to be significant at 0.05% (n= 3).
Table 2 Minimum inhibitory concentration (MIC) of bioac-
tive compounds isolated from Pseudonocardia endophytica
VUK-10 MIC-(lg/ml)) against dermatophytes and fungi.
Dermatophytes Compound-1 Compound-2 Antifungal
agent
Candida albicans 32 32 16
Epidermophyton
floccosum
64 16 16
Fungi
Figure 1 Molecular structure of (3S,8aS)-3-isobutylhexahy-
dropyrrolo[1,2-a]pyrazine-1,4-dione (1) (Cyclo (D-Pro-D-Leu).
172 U.K. Mangamuri et al.+Na) (Supplementary Fig. G). The IR spectrum displayed
absorption bands at Vmax 3260, 2953, 1672, 1635, 1432 and
709 cm1 (Supplementary Fig. H). Based on the above spectral
data, bioactive compound 2 was identified as (3R,8aS)-3-isobu
tylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione (Cyclo (L-Pro-D-
Leu) with the molecular formula of C11H18N2O2 (Fig. 2).
Minimum inhibitory concentration (MIC) assay
Antibacterial activities of the bioactive compounds (1 and 2) in
terms of MIC are shown in Table 1. The bioactive compounds
exhibited antibacterial activity against a variety of gram-
positive and gram-negative bacteria, for which the MIC values
ranged from 4 to 256 lg/ml. The best activity of compound 1
was recorded against X. campestris and E. coli (8 lg/ml) fol-
lowed by X. malvacearum, B. subtilis and P. aeruginosa
(32 lg/ml). The microorganism that presented highest sensitiv-
ity toward compound 2 was B. subtilis (4 lg/ml) followed by X.
campestris and E. coli (16 lg/ml). Tetracycline served as the
positive control for the bacteria. Compared with the standard
drug tetracycline, compounds 1 and 2 displayed high sensitiv-
ity against X. campestris and B. subtilis, while in some cases
compound 1 (B. subtilis; E. coli) and 2 (X. campestris) recorded
similar sensitivity like positive control (Table 1). Tetracycline,
in other cases showed good antibacterial activity over the
metabolites of the strain.
Antifungal activity against dermatophytes and filamentous
fungi and the corresponding MIC values are recorded in
Table 2. Compound 2 exhibited significant MIC value against
E. floccosum (16 lg/ml) whereas compounds 1 and 2 recorded
activity at 32 lg/ml against C. albicans. Among the filamen-Figure 2 Molecular structure of (3R,8aS)-3-isobutylhexahy-
dropyrrolo[1,2-a]pyrazine-1,4-dione (2) (Cyclo (L-Pro-D-Leu).tous fungi tested, A. flavus recorded sensitivity of 16 lg/ml
toward compound 1, and A. alternata that recorded no activity
up to 512 lg/ml. Compound 2 was active against F. oxysporum
at 32 lg/ml, and for this compound V. alboatrum recorded no
activity up to 1000 lg/ml (Table 2). Both compounds recorded
lower antifungal activity than the standard fungicide,
Amphotericin-B against fungi.Aspergillus niger 64 128 16
Aspergillus flavus 16 128 8
Fusarium oxysporum 256 32 16
Fusarium solani 128 128 32
Penicillium citrinum 128 256 8
Verticillium alboatrum 256 ND 64
Alternaria alternata >512 256 32
Compound-1: (3S,8aS)-3-isobutylhexahydropyrrolo[1,2-a]pyr-
azine-1,4-dione.
Compound-2: (3R,8aS)-3-isobutylhexahydropyrrolo[1,2-a]pyr-
azine-1,4-dione.
Antifungal agent: Griseofulvin against yeast and Amphotericin-B
against fungi.
ND, not detected.
Data were statistically analyzed by one way ANOVA variance and
found to be significant at 0.05% (n= 3).
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The cytotoxicity of the purified compounds 1 and 2 was
assayed against MDA-MB-231, HeLa, MCF-7 and OAW-42.
The results exhibited that both compounds were active against
the four cell lines.
The activity of compound 1 against MDA-MB-231, HeLa,
MCF-7 and OAW-42 cell lines is presented in Fig. 3 (A–D).
Compound 1 showed significant cytotoxicity when evaluated
against MDA-MB-231, HeLa, MCF-7 and OAW-42 cell lines,
displaying IC50 values of 100 lM (55.8%) (MDA-MB-231),
10 lM (62.8%) (HeLa), 1000 lM (55.8%) (MCF-7) and
5000 lM (53%) (OAW-42).
The activity of compound 2 against MDA-MB-231,
HeLa, MCF-7 and OAW-42 cell lines is presented in
Fig. 4 (A–D). Compound 2 exhibited potent cytotoxicity
with MDA-MB-231, HeLa, MCF-7 and OAW-42 cell lines,
exhibiting IC50 values of 1000 lM (50%, 51.2%) (MDA-
MB-231, MCF-7), 10 lM (60.4%) (HeLa) and 100 lM
(50.7%) (OAW-42). Taxol, an anticancer drug used as the
standard, recorded an IC50 value of 10 nM (59%, 60%,
57% and 63%) against the MDA-MB-231, HeLa, OAW-42
and MCF-7 cell lines.Figure 3 Dose response curve of Compound-1 on the growth of (A)
of the percentage of the cell viability was statistically analyzed by a one
were expressed as mean ± deviation and were considered statisticallyDiscussion
Diketopiperazines (DKP’S) are privileged structures for the
authentication of contemporary lead compounds by combina-
torial chemistry and considered exemplary for the enlightened
augmentation of new therapeutic agents. They target a broad
array of receptors with high affinity, dispensing an extensive
spectrum of biological activities (Maristela and Ivone, 2007).
DKP derivatives, originated naturally by many organisms,
unfold a great number of multiple structures and biological
functions, enabling them as useful chemical entities for the
expedition and improvement of new drugs (Smaoui et al.,
2012). Especially, some DKPs bearing proline residues isolated
from marine organisms were found to have diversified bioac-
tivities such as anti-inflammatory agents, immune modulators
and tumoral cytotoxic agents (Huang et al., 2010). In the pre-
sent study, the extraction and further purification of the sec-
ondary metabolites of the strain grown on glucose–soy
peptone broth led to the isolation of two proline containing
cyclic dipeptides, (3S,8aS)-3-isobutylhexahydropyrrolo[1,2-a]
pyrazine-1,4-dione (1) (Cyclo (D-Pro-D-Leu) and (3R, 8aS)-3-
isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione (2) (Cyclo
(L-Pro-D-Leu) which were effective against pathogenic bacte-
ria, fungi and cancer cell lines.MDB-MB-231 (B) HeLa (C) MCF-7 (D) OAW-42 cell lines. Data
-way ANOVA. The results from the three independent experiments
significant for a p-value lower than 0.05% (p< 0.05).
Figure 4 Dose response curve of Compound-2 on the growth of (A) MDB-MB-231 (B) HeLa (C) MCF-7 (D) OAW-42 cell lines. Data
of the percentage of the cell viability was statistically analyzed by one-way ANOVA analysis. The results from the three independent
experiments were expressed as mean ± deviation and were considered statistically significant for a p-value lower than 0.05% (p< 0.05).
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10 is the first communication in literature with complete struc-
tural characterization. The two DKPs acknowledged in this
study were marginally diverse from the other compounds.
Compound 1 has S-Leu and compound 2 has R-Leu. The
NMR spectral data and optical rotation values obtained for
compounds indicated that compound 1 is a diastereomer of
compound 2. Compound 1 was previously reported as a natu-
ral product from bacteria (Yang et al., 2002) and marine
sponges (Wegerski et al., 2004). The production of compound
2 was previously reported from a marine derived Streptomyces
sp. (Bin et al., 2011). Antibacterial activity of Cyclo (Leu-Pro)
was reported on vancomycin resistant Enterococcus faecalis
strains (Rhee et al., 2001).
Our results emphasize that compound 1 is an exceptionally
potential inhibitor against X. campestris (causes bacterial leaf
spot on peppers and tomatoes), E. coli (causes cholecystitis,
bacteremia, cholangitis and urinary tract infection) C. albicans
and A. flavus (causes aspergillosis). It was demonstrated that
Cyclo (L-Leu-L-Pro) was shown to possess MIC of 16 lg/ml
against pathogenic bacteria E. coli (Rhee, 2004). We observed
a greater potency against same bacteria with inhibition at
8 lg/ml, for compound 1. Similarly anti fungal activity of
Cyclo (L-Leu-L-Pro) was previously reported against Aspergillus
parasiticus with inhibition at a range of 0.2 mg/ml (Yan et al.,
2004), whereas compound 1 displayed superior activity with
16 lg/ml against a similar variety of fungus,A. flavus. This might
be due to the chirality variation in the amino acids causing aneffect on topography of the molecule and thus resulting in biased
inhibition. Compound 2 results indicate antimicrobial activity
against B. subtilis (causes disease in severely immune compro-
mised patients), E. floccosum (causes tinea pedis, tinea cruris
and tinea corporis), C. albicans (causes oral thrush and vaginal
infection) and F. oxysporum (causes fusarium wilt, fungal kerati-
tis and onychomycosis). Anti microbial studies of compound 2
were less explored; however, the present study recorded superior
antibacterial activity against B. subtilis than the positive control
tetracycline. Anti cancer activity of Cyclo (Leu-Pro) was previ-
ously documented against HeLa and MCF-7 cell lines (Brauns
et al., 2004). The results in the present study registered phenom-
enal potency across similar cell lines. In addition, anti cancer
activity of compounds 1 and 2 against MDA-MB-231 and
OAW-42 cell lines Germana et al. (2015), reported in the study
for the first time. The data cataloged in this paper apparently jus-
tified that our compounds illustrated convincing anti cancer
activities at nanomolar concentrations.
The bioactive compounds of the current work purified from
strain VUK-10 showed significant antimicrobial activity
against gram positive, gram negative bacteria, dermatophytes
and filamentous fungi. On the other hand potent cytotoxic
activity recorded against MDA-MB-231, HeLa, OAW-42
and MCF-7 cell lines. Hence, the strain is an important and
encouraging microorganism enable to produce antimicrobial
and cytotoxic compounds. This is the first report on isolation
and characterization of compounds, (3S,8aS)-3-isobutylhexa
hydropyrrolo[1,2-a]pyrazine-1,4-dione (1) and (3R,8aS)-3-iso
Bioactive compounds from the Mangrove Derived Actinomycetes 175butylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione (2) from
genus Pseudonocardia.
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